Cara Therapeutics Inc (CARA)
0.3087
0.00 (0.00%)
USD |
NASDAQ |
Nov 22, 16:00
0.3087
0.00 (0.00%)
After-Hours: 19:10
Cara Therapeutics Total Assets (Quarterly): 51.33M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 51.33M |
| June 30, 2024 | 72.50M |
| March 31, 2024 | 90.10M |
| December 31, 2023 | 125.84M |
| September 30, 2023 | 115.34M |
| June 30, 2023 | 134.39M |
| March 31, 2023 | 153.28M |
| December 31, 2022 | 182.24M |
| September 30, 2022 | 213.51M |
| June 30, 2022 | 226.57M |
| March 31, 2022 | 223.87M |
| December 31, 2021 | 247.06M |
| September 30, 2021 | 225.09M |
| June 30, 2021 | 221.45M |
| March 31, 2021 | 250.23M |
| December 31, 2020 | 271.16M |
| September 30, 2020 | 147.14M |
| June 30, 2020 | 168.61M |
| March 31, 2020 | 196.17M |
| December 31, 2019 | 232.96M |
| September 30, 2019 | 263.80M |
| June 30, 2019 | 149.64M |
| March 31, 2019 | 170.59M |
| Date | Value |
|---|---|
| December 31, 2018 | 190.82M |
| September 30, 2018 | 212.70M |
| June 30, 2018 | 139.89M |
| March 31, 2018 | 80.64M |
| December 31, 2017 | 97.00M |
| September 30, 2017 | 108.05M |
| June 30, 2017 | 117.97M |
| March 31, 2017 | 43.30M |
| December 31, 2016 | 63.83M |
| September 30, 2016 | 80.15M |
| June 30, 2016 | 92.04M |
| March 31, 2016 | 102.01M |
| December 31, 2015 | 110.90M |
| September 30, 2015 | 117.90M |
| June 30, 2015 | 46.44M |
| March 31, 2015 | 51.65M |
| December 31, 2014 | 55.93M |
| September 30, 2014 | 62.37M |
| June 30, 2014 | 68.19M |
| March 31, 2014 | 71.56M |
| December 31, 2013 | 18.08M |
| September 30, 2013 | 22.07M |
| December 31, 2012 | 5.537M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
51.33M
Minimum
Sep 2024
271.16M
Maximum
Dec 2020
177.44M
Average
189.20M
Median
Total Assets (Quarterly) Benchmarks
| Agilent Technologies Inc | 11.00B |
| Seelos Therapeutics Inc | 2.381M |
| Citius Pharmaceuticals Inc | 97.09M |
| Moleculin Biotech Inc | 23.39M |
| NovaBay Pharmaceuticals Inc | 3.877M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 50.62M |
| Shareholders Equity (Quarterly) | 0.707M |
| Current Ratio | 4.773 |